Breaking News Instant updates and real-time market news.

CBGPY

Close Brothers

$0.00 /

+ (+0.00%)

05:15
07/06/20
07/06
05:15
07/06/20
05:15

Close Brothers upgraded to Hold from Sell at Canaccord

Canaccord Genuity analyst Portia Patel upgraded Close Brothers to Hold from Sell with a EUR 1,197 price target.

CBGPY Close Brothers
$0.00 /

+ (+0.00%)

07/01/20 RBC Capital
Close Brothers upgraded to Outperform from Sector Perform at RBC Capital
05/27/20 Investec
Close Brothers downgraded to Sell from Hold at Investec
04/27/20 Jefferies
Close Brothers downgraded to Underperform from Hold at Jefferies
04/24/20 JPMorgan
Close Brothers price target lowered to 1,170 GBp from 1,550 GBp at JPMorgan

TODAY'S FREE FLY STORIES

Hot Stocks
Provectus announces release of manuscript on PV-10 preclinical study » 07:10
01/20/21
01/20
07:10
01/20/21
07:10
PVCT

Provectus

$0.00 /

+ (+0.00%)

Provectus announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PVCT Provectus
$0.00 /

+ (+0.00%)

Hot Stocks
Forma Therapeutics announces first patient dosed in FT-7051 trial » 07:10
01/20/21
01/20
07:10
01/20/21
07:10
FMTX

Forma Therapeutics

$37.48 /

-0.0898 (-0.24%)

Forma Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FMTX Forma Therapeutics
$37.48 /

-0.0898 (-0.24%)

FMTX Forma Therapeutics
$37.48 /

-0.0898 (-0.24%)

12/22/20 Cantor Fitzgerald
Agios oncology deal a positive read to FT-4202 strategy, says Cantor Fitzgerald
12/09/20 BMO Capital
Agios Pharmaceuticals price target lowered to $50 from $57 at BMO Capital
12/08/20 Cantor Fitzgerald
Forma Therapeutics price target raised to $68 from $61 at Cantor Fitzgerald
12/08/20 SVB Leerink
Forma Therapeutics price target raised to $65 from $54 at SVB Leerink
FMTX Forma Therapeutics
$37.48 /

-0.0898 (-0.24%)

  • 11
    Dec
  • 19
    Jun
Recommendations
MercadoLibre price target raised to $2,150 from $1,300 at Citi » 07:10
01/20/21
01/20
07:10
01/20/21
07:10
MELI

MercadoLibre

$1,911.40 /

+57.33 (+3.09%)

Citi analyst Tobias…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MELI MercadoLibre
$1,911.40 /

+57.33 (+3.09%)

MELI MercadoLibre
$1,911.40 /

+57.33 (+3.09%)

01/19/21 HSBC
MercadoLibre price target raised to $2,100 from $1,800 at HSBC
01/04/21 Barclays
MercadoLibre assumed with an Overweight at Barclays
12/22/20 Santander
MercadoLibre upgraded to Buy from Hold at Santander
12/17/20 BTIG
MercadoLibre downgraded to Neutral after 192% rally at BTIG
MELI MercadoLibre
$1,911.40 /

+57.33 (+3.09%)

MELI MercadoLibre
$1,911.40 /

+57.33 (+3.09%)

MELI MercadoLibre
$1,911.40 /

+57.33 (+3.09%)

Hot Stocks
Oncorus announces publication of preclinical data on ONCR-177 study » 07:09
01/20/21
01/20
07:09
01/20/21
07:09
ONCR

Oncorus

$28.52 /

-0.33 (-1.14%)

Oncorus announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ONCR Oncorus
$28.52 /

-0.33 (-1.14%)

ONCR Oncorus
$28.52 /

-0.33 (-1.14%)

11/11/20 Piper Sandler
Oncorus timelines remain on track after Q3 results, says Piper Sandler
10/27/20 Jefferies
Oncorus initiated with a Buy at Jefferies
10/27/20 Evercore ISI
Oncorus initiated with an Outperform at Evercore ISI
10/27/20 Piper Sandler
Oncorus initiated with an Overweight at Piper Sandler
ONCR Oncorus
$28.52 /

-0.33 (-1.14%)

  • 02
    Oct
ONCR Oncorus
$28.52 /

-0.33 (-1.14%)

Recommendations
Intel investors watching long term strategic direction, says Susquehanna » 07:09
01/20/21
01/20
07:09
01/20/21
07:09
INTC

Intel

$58.01 /

+0.42 (+0.73%)

Susquehanna analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INTC Intel
$58.01 /

+0.42 (+0.73%)

INTC Intel
$58.01 /

+0.42 (+0.73%)

01/15/21 Evercore ISI
Evercore adds Dell Technologies to tactical Outperform list, ups target to $85
01/15/21 DZ Bank
Intel upgraded to Hold from Sell at DZ Bank
01/14/21
Fly Intel: Top five analyst upgrades
01/14/21 Needham
Intel upgraded to Buy from Hold at Needham
INTC Intel
$58.01 /

+0.42 (+0.73%)

INTC Intel
$58.01 /

+0.42 (+0.73%)

INTC Intel
$58.01 /

+0.42 (+0.73%)

INTC Intel
$58.01 /

+0.42 (+0.73%)

Hot Stocks
Aveo Pharmaceuticals to receive an n incremental $10M loan from Hercules » 07:09
01/20/21
01/20
07:09
01/20/21
07:09
AVEO

Aveo Pharmaceuticals

$8.55 /

+0.37 (+4.52%)

, HTGC

Hercules Capital

$15.13 /

+0.22 (+1.48%)

AVEO Oncology (AVEO)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AVEO Aveo Pharmaceuticals
$8.55 /

+0.37 (+4.52%)

HTGC Hercules Capital
$15.13 /

+0.22 (+1.48%)

AVEO Aveo Pharmaceuticals
$8.55 /

+0.37 (+4.52%)

11/09/20
Fly Intel: Top five analyst initiations
11/09/20 Stifel
Aveo Pharmaceuticals initiated with a Buy at Stifel
08/13/20 SVB Leerink
SVB Leerink bullish on Aveo Pharmaceuticals, initiates with an Outperform
08/13/20 SVB Leerink
Aveo Pharmaceuticals initiated with an Outperform at SVB Leerink
HTGC Hercules Capital
$15.13 /

+0.22 (+1.48%)

01/08/21 Piper Sandler
Hercules Capital price target raised to $16 from $13 at Piper Sandler
11/24/20 B. Riley Securities
Hercules Capital price target raised to $14.50 from $12.50 at B. Riley
11/19/20 JMP Securities
TriplePoint Venture resumed with an Outperform at JMP Securities
07/31/20 Compass Point
Hercules upgraded to Buy on credit performance at Compass Point
AVEO Aveo Pharmaceuticals
$8.55 /

+0.37 (+4.52%)

HTGC Hercules Capital
$15.13 /

+0.22 (+1.48%)

  • 17
    Jun
AVEO Aveo Pharmaceuticals
$8.55 /

+0.37 (+4.52%)

Downgrade
Cemex downgraded to Neutral from Buy at Citi » 07:08
01/20/21
01/20
07:08
01/20/21
07:08
CX

Cemex

$6.68 /

+0.285 (+4.46%)

Citi analyst Andres…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CX Cemex
$6.68 /

+0.285 (+4.46%)

CX Cemex
$6.68 /

+0.285 (+4.46%)

01/15/21 Barclays
Cemex price target raised to $7 from $5 at Barclays
11/30/20 BBVA
Cemex upgraded to Outperform from Market Perform at BBVA
11/20/20 Santander
Cemex downgraded to Hold from Buy at Santander
11/17/20 Citi
Cemex initiated with a Buy at Citi
CX Cemex
$6.68 /

+0.285 (+4.46%)

CX Cemex
$6.68 /

+0.285 (+4.46%)

CX Cemex
$6.68 /

+0.285 (+4.46%)

Hot Stocks
Eloxx Pharmaceuticals announces publication of manuscript on ELX-02 » 07:08
01/20/21
01/20
07:08
01/20/21
07:08
ELOX

Eloxx Pharmaceuticals

$4.08 /

-0.06 (-1.45%)

Eloxx Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ELOX Eloxx Pharmaceuticals
$4.08 /

-0.06 (-1.45%)

ELOX Eloxx Pharmaceuticals
$4.08 /

-0.06 (-1.45%)

06/17/20 Piper Sandler
Piper Sandler backs Overweight on Eloxx as cystic fibrosis trials resume
06/11/20
Fly Intel: Top five analyst downgrades
06/11/20 Citi
Citi downgrades Eloxx Pharmaceuticals on cystic fibrosis trial pause
06/10/20 Citi
Eloxx Pharmaceuticals downgraded to Neutral from Buy at Citi
ELOX Eloxx Pharmaceuticals
$4.08 /

-0.06 (-1.45%)

Earnings
Procter & Gamble raises FY21 core EPS view to up 8%-10% from up 5%-8% » 07:08
01/20/21
01/20
07:08
01/20/21
07:08
PG

Procter & Gamble

$133.56 /

-1.275 (-0.95%)

Consensus $5.59. Raises…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PG Procter & Gamble
$133.56 /

-1.275 (-0.95%)

PG Procter & Gamble
$133.56 /

-1.275 (-0.95%)

01/19/21 Bernstein
Procter & Gamble initiated with a Market Perform at Bernstein
01/13/21 Deutsche Bank
Procter & Gamble price target raised to $159 from $156 at Deutsche Bank
01/06/21 Evercore ISI
PepsiCo downgraded to In Line to reflect macro view at Evercore ISI
12/07/20 Wells Fargo
Colgate-Palmolive initiated with an Underweight at Wells Fargo
PG Procter & Gamble
$133.56 /

-1.275 (-0.95%)

PG Procter & Gamble
$133.56 /

-1.275 (-0.95%)

PG Procter & Gamble
$133.56 /

-1.275 (-0.95%)

PG Procter & Gamble
$133.56 /

-1.275 (-0.95%)

Initiation
EDP Renovaveis resumed with an Equal Weight at Morgan Stanley » 07:07
01/20/21
01/20
07:07
01/20/21
07:07
EDRVF

EDP Renovaveis

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EDRVF EDP Renovaveis
$0.00 /

+ (+0.00%)

01/12/21 Barclays
EDP Renovaveis price target raised to EUR 24.80 from EUR 17.80 at Barclays
01/12/21 Kepler Cheuvreux
EDP Renovaveis downgraded to Hold from Buy at Kepler Cheuvreux
01/11/21 JPMorgan
EDP Renovaveis downgraded to Neutral from Overweight at JPMorgan
01/10/21 Goldman Sachs
EDP Renovaveis downgraded to Buy from Conviction Buy at Goldman Sachs
Earnings
ASML sees Q1 net sales EUR 3.9B-EUR 4.1B, gross margin 50%-51%  07:07
01/20/21
01/20
07:07
01/20/21
07:07
ASML

ASML

$549.18 /

+21.25 (+4.03%)

 
ShowHide Related Items >><<
ASML ASML
$549.18 /

+21.25 (+4.03%)

01/19/21 Barclays
ASML price target raised to EUR 525 from EUR 475 at Barclays
01/15/21 JPMorgan
ASML price target raised to EUR 437 from EUR 408 at JPMorgan
01/14/21 Barclays
ASML price target raised to EUR 475 from EUR 425 at Barclays
01/13/21 UBS
ASML price target raised to EUR 430 from EUR 395 at UBS
ASML ASML
$549.18 /

+21.25 (+4.03%)

ASML ASML
$549.18 /

+21.25 (+4.03%)

Hot Stocks
Evelo Biosciences reports confirmatory data from Phase 1b trial of EDP1815 » 07:06
01/20/21
01/20
07:06
01/20/21
07:06
EVLO

Evelo Biosciences

$15.49 /

+1.23 (+8.63%)

Evelo Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVLO Evelo Biosciences
$15.49 /

+1.23 (+8.63%)

EVLO Evelo Biosciences
$15.49 /

+1.23 (+8.63%)

12/30/20 JMP Securities
Evelo shares undervalued into atopic dermatitis data, says JMP Securities
12/23/20 JMP Securities
Evelo Biosciences initiated with an Outperform at JMP Securities
09/18/20 Chardan
Seres Therapeutics downgraded to Neutral from Buy at Chardan
07/02/20 BMO Capital
Evelo Biosciences price target lowered to $17 from $21 at BMO Capital
EVLO Evelo Biosciences
$15.49 /

+1.23 (+8.63%)

  • 25
    Jun
Initiation
J.M. Smucker initiated with a Neutral at Citi » 07:06
01/20/21
01/20
07:06
01/20/21
07:06
SJM

J.M. Smucker

$115.65 /

+1.545 (+1.35%)

Citi analyst Wendy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SJM J.M. Smucker
$115.65 /

+1.545 (+1.35%)

SJM J.M. Smucker
$115.65 /

+1.545 (+1.35%)

01/19/21 JPMorgan
J.M. Smucker price target lowered to $115 from $122 at JPMorgan
09/16/20 Morgan Stanley
J.M. Smucker price target lowered to $106 from $114 at Morgan Stanley
08/26/20
Fly Intel: Top five analyst upgrades
08/26/20 Deutsche Bank
J.M. Smucker price target raised to $127 from $121 at Deutsche Bank
SJM J.M. Smucker
$115.65 /

+1.545 (+1.35%)

SJM J.M. Smucker
$115.65 /

+1.545 (+1.35%)

SJM J.M. Smucker
$115.65 /

+1.545 (+1.35%)

SJM J.M. Smucker
$115.65 /

+1.545 (+1.35%)

Earnings
ASML reports Q4 EPS EUR 3.23 vs. EUR 2.54 last quarter » 07:06
01/20/21
01/20
07:06
01/20/21
07:06
ASML

ASML

$549.18 /

+21.25 (+4.03%)

Reports Q4 net sales EUR…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASML ASML
$549.18 /

+21.25 (+4.03%)

01/19/21 Barclays
ASML price target raised to EUR 525 from EUR 475 at Barclays
01/15/21 JPMorgan
ASML price target raised to EUR 437 from EUR 408 at JPMorgan
01/14/21 Barclays
ASML price target raised to EUR 475 from EUR 425 at Barclays
01/13/21 UBS
ASML price target raised to EUR 430 from EUR 395 at UBS
ASML ASML
$549.18 /

+21.25 (+4.03%)

ASML ASML
$549.18 /

+21.25 (+4.03%)

Hot Stocks
Ocuphire Pharma reports results from ORION-1 Phase 2 clinical trial » 07:06
01/20/21
01/20
07:06
01/20/21
07:06
OCUP

Ocuphire Pharma

$7.81 /

+0.75 (+10.62%)

Ocuphire Pharma announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OCUP Ocuphire Pharma
$7.81 /

+0.75 (+10.62%)

OCUP Ocuphire Pharma
$7.81 /

+0.75 (+10.62%)

11/19/20 Cantor Fitzgerald
Ocuphire Pharma initiated with an Overweight at Cantor Fitzgerald
Initiation
Energias de Portugal resumed with an Overweight at Morgan Stanley » 07:06
01/20/21
01/20
07:06
01/20/21
07:06
EDPFY

Energias de Portugal

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EDPFY Energias de Portugal
$0.00 /

+ (+0.00%)

09/21/20 RBC Capital
Energias de Portugal upgraded to Sector Perform at RBC Capital
09/16/20 Credit Suisse
Energias de Portugal price target raised to EUR 5 at Credit Suisse
08/28/20 JPMorgan
Energias de Portugal price target raised to EUR 4.65 from EUR 4.50 at JPMorgan
08/23/20 Goldman Sachs
Energias de Portugal upgraded to Conviction Buy from Buy at Goldman Sachs
Hot Stocks
Applied DNA Sciences promotes Judith Murrah to the role of COO » 07:04
01/20/21
01/20
07:04
01/20/21
07:04
APDN

Applied DNA Sciences

$11.17 /

+0.1901 (+1.73%)

Applied DNA Sciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APDN Applied DNA Sciences
$11.17 /

+0.1901 (+1.73%)

APDN Applied DNA Sciences
$11.17 /

+0.1901 (+1.73%)

01/14/21 H.C. Wainwright
Applied DNA Sciences price target lowered to $14 from $18 at H.C. Wainwright
01/11/21 H.C. Wainwright
Applied DNA Sciences price target raised to $18 from $12 at H.C. Wainwright
12/30/20 H.C. Wainwright
H.C. Wainwright keeps $12 target on Applied DNA Sciences after partnership
12/18/20 H.C. Wainwright
Applied DNA Sciences price target lowered to $12 from $20 at H.C. Wainwright
APDN Applied DNA Sciences
$11.17 /

+0.1901 (+1.73%)

Hot Stocks
Main Street reports Q4 private loan activity » 07:04
01/20/21
01/20
07:04
01/20/21
07:04
MAIN

Main Street

$32.63 /

+0.31 (+0.96%)

Main Street reported…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MAIN Main Street
$32.63 /

+0.31 (+0.96%)

MAIN Main Street
$32.63 /

+0.31 (+0.96%)

08/12/20 Truist
Main Street price target raised to $33 from $28 at Truist
04/15/20 National Securities
Main Street downgraded to Neutral from Buy at National Securities
03/17/20 National Securities
Main Street upgraded to Buy from Neutral at National Securities
MAIN Main Street
$32.63 /

+0.31 (+0.96%)

Earnings
Murphy USA reports preliminary 2020 EPS $13.08, consensus $13.18 » 07:04
01/20/21
01/20
07:04
01/20/21
07:04
MUSA

Murphy USA

$124.84 /

+0.37 (+0.30%)

"As we exit 2020, we…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MUSA Murphy USA
$124.84 /

+0.37 (+0.30%)

MUSA Murphy USA
$124.84 /

+0.37 (+0.30%)

01/04/21 Stephens
Brinker, LiveRamp and Vonage among 2021 best ideas at Stephens
12/01/20
Fly Intel: Top five analyst initiations
12/01/20 Goldman Sachs
Murphy USA initiated with a Sell at Goldman Sachs
11/20/20 Jefferies
Murphy USA assumed with a Hold at Jefferies
MUSA Murphy USA
$124.84 /

+0.37 (+0.30%)

MUSA Murphy USA
$124.84 /

+0.37 (+0.30%)

Earnings
Procter & Gamble reports Q2 core EPS $1.64, consensus $1.51 » 07:03
01/20/21
01/20
07:03
01/20/21
07:03
PG

Procter & Gamble

$133.56 /

-1.275 (-0.95%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PG Procter & Gamble
$133.56 /

-1.275 (-0.95%)

PG Procter & Gamble
$133.56 /

-1.275 (-0.95%)

01/19/21 Bernstein
Procter & Gamble initiated with a Market Perform at Bernstein
01/13/21 Deutsche Bank
Procter & Gamble price target raised to $159 from $156 at Deutsche Bank
01/06/21 Evercore ISI
PepsiCo downgraded to In Line to reflect macro view at Evercore ISI
12/07/20 Wells Fargo
Colgate-Palmolive initiated with an Underweight at Wells Fargo
PG Procter & Gamble
$133.56 /

-1.275 (-0.95%)

PG Procter & Gamble
$133.56 /

-1.275 (-0.95%)

PG Procter & Gamble
$133.56 /

-1.275 (-0.95%)

PG Procter & Gamble
$133.56 /

-1.275 (-0.95%)

Recommendations
Citi adds PPG to US Focus List, removes FMC » 07:03
01/20/21
01/20
07:03
01/20/21
07:03
PPG

PPG

$145.00 /

-3 (-2.03%)

, FMC

FMC Corporation

$116.60 /

-3.43 (-2.86%)

Citi analyst P.J. Juvekar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PPG PPG
$145.00 /

-3 (-2.03%)

FMC FMC Corporation
$116.60 /

-3.43 (-2.86%)

PPG PPG
$145.00 /

-3 (-2.03%)

01/14/21 Berenberg
PPG upgraded to Buy with $165 price target at Berenberg
01/14/21 Berenberg
PPG upgraded to Buy from Hold at Berenberg
12/01/20 Deutsche Bank
PPG price target raised to $165 from $155 at Deutsche Bank
12/01/20 Barclays
PPG price target raised to $155 from $151 at Barclays
FMC FMC Corporation
$116.60 /

-3.43 (-2.86%)

06:44 Today Citi
FMC Corporation price target lowered to $138 from $141 at Citi
11/20/20
Fly Intel: Top five analyst initiations
11/20/20 Bernstein
FMC Corporation initiated with a Market Perform at Bernstein
11/18/20 BMO Capital
FMC Corporation price target raised to $124 from $120 at BMO Capital
PPG PPG
$145.00 /

-3 (-2.03%)

FMC FMC Corporation
$116.60 /

-3.43 (-2.86%)

PPG PPG
$145.00 /

-3 (-2.03%)

FMC FMC Corporation
$116.60 /

-3.43 (-2.86%)

PPG PPG
$145.00 /

-3 (-2.03%)

Hot Stocks
Imara appoints Kenneth Atttie as Chief Medical Officer » 07:03
01/20/21
01/20
07:03
01/20/21
07:03
IMRA

Imara

$14.08 /

+0.38 (+2.77%)

Imara announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IMRA Imara
$14.08 /

+0.38 (+2.77%)

IMRA Imara
$14.08 /

+0.38 (+2.77%)

01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
06/30/20 Citi
Imara downgraded to Neutral from Buy at Citi
IMRA Imara
$14.08 /

+0.38 (+2.77%)

  • 12
    Mar
IMRA Imara
$14.08 /

+0.38 (+2.77%)

Earnings
Murphy USA reports preliminary Q4 EPS $2.16, consensus $1.94 » 07:03
01/20/21
01/20
07:03
01/20/21
07:03
MUSA

Murphy USA

$124.84 /

+0.37 (+0.30%)

Net income for the fourth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MUSA Murphy USA
$124.84 /

+0.37 (+0.30%)

MUSA Murphy USA
$124.84 /

+0.37 (+0.30%)

01/04/21 Stephens
Brinker, LiveRamp and Vonage among 2021 best ideas at Stephens
12/01/20
Fly Intel: Top five analyst initiations
12/01/20 Goldman Sachs
Murphy USA initiated with a Sell at Goldman Sachs
11/20/20 Jefferies
Murphy USA assumed with a Hold at Jefferies
MUSA Murphy USA
$124.84 /

+0.37 (+0.30%)

MUSA Murphy USA
$124.84 /

+0.37 (+0.30%)

Hot Stocks
Fulton Financial sees 2021 net interest income $620M-$640M » 07:02
01/20/21
01/20
07:02
01/20/21
07:02
FULT

Fulton Financial

$14.79 /

+0.28 (+1.93%)

Sees 2021 provision for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FULT Fulton Financial
$14.79 /

+0.28 (+1.93%)

FULT Fulton Financial
$14.79 /

+0.28 (+1.93%)

06/17/20 Raymond James
Fulton Financial upgraded to Outperform from Market Perform at Raymond James
06/01/20 Stephens
Fulton Financial initiated with an Equal Weight at Stephens
FULT Fulton Financial
$14.79 /

+0.28 (+1.93%)

FULT Fulton Financial
$14.79 /

+0.28 (+1.93%)

Initiation
Aalberts initiated with an Overweight at Morgan Stanley » 07:02
01/20/21
01/20
07:02
01/20/21
07:02
AALBF

Aalberts

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AALBF Aalberts
$0.00 /

+ (+0.00%)

07/28/20 Kepler Cheuvreux
Aalberts upgraded to Buy from Hold at Kepler Cheuvreux
07/24/20 ABN Amro
Aalberts upgraded to Buy from Hold at ABN Amro

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.